Complete regression of advanced HCC with long acting octreotide.
Siveke
J T
JT
Herberhold
C
C
Folwaczny
C
C
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*; D012074:Remission Induction
D018931:Antineoplastic Agents, Hormonal; D003692:Delayed-Action Preparations; D015282:Octreotide